Reversal of peripheral nerve injury-induced hypersensitivity in the postpartum period: role of spinal oxytocin.
Silvia Gutierrez, Baogang Liu, Ken-ichiro Hayashida, Timothy T Houle, James C Eisenach
Index: Anesthesiology 118(1) , 152-9, (2013)
Full Text: HTML
Abstract
Physical injury, including surgery, can result in chronic pain; yet chronic pain following childbirth, including cesarean delivery in women, is rare. The mechanisms involved in this protection by pregnancy or delivery have not been explored.We examined the effect of pregnancy and delivery on hypersensitivity to mechanical stimuli of the rat hindpaw induced by peripheral nerve injury (spinal nerve ligation) and after intrathecal oxytocin, atosiban, and naloxone. Additionally, oxytocin concentration in lumbar spinal cerebrospinal fluid was determined.Spinal nerve ligation performed at mid-pregnancy resulted in similar hypersensitivity to nonpregnant controls, but hypersensitivity partially resolved beginning after delivery. Removal of pups after delivery prevented this partial resolution. Cerebrospinal fluid concentrations of oxytocin were greater in normal postpartum rats prior to weaning. To examine the effect of injury at the time of delivery rather than during pregnancy, spinal nerve ligation was performed within 24 h of delivery. This resulted in acute hypersensitivity that partially resolved over the next 2-3 weeks. Weaning of pups resulted only in a temporary return of hypersensitivity. Intrathecal oxytocin effectively reversed the hypersensitivity following separation of the pups. Postpartum resolution of hypersensitivity was transiently abolished by intrathecal injection of the oxytocin receptor antagonist, atosiban.These results suggest that the postpartum period rather than pregnancy protects against chronic hypersensitivity from peripheral nerve injury and that this protection may reflect sustained oxytocin signaling in the central nervous system during this period.
Related Compounds
Related Articles:
Development and clinical experience with the new evidence-based tocolytic atosiban.
2002-07-01
[Acta Obstet. Gynecol. Scand. 81(7) , 633-41, (2002)]
2012-07-01
[Addict. Biol. 17(4) , 758-69, (2012)]
Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban.
1998-01-01
[J. Perinat. Med. 26(6) , 458-65, (1998)]
2012-02-01
[Anesth. Analg. 114(2) , 442-9, (2012)]
2003-12-01
[BJOG 110(12) , 1045-9, (2003)]